Wells Fargo & Company Increases Bristol-Myers Squibb (NYSE:BMY) Price Target to $62.00
Bristol-Myers Squibb (NYSE:BMY – Free Report) had its target price increased by Wells Fargo & Company from $60.00 to $62.00 in a report published on Friday morning,Benzinga reports. They currently have an equal weight rating on the biopharmaceutical company’s stock. Several other analysts also recently commented on BMY. Daiwa Capital Markets raised Bristol-Myers Squibb from […]
Bristol-Myers Squibb (NYSE:BMY – Free Report) had its target price increased by Wells Fargo & Company from $60.00 to $62.00 in a report published on Friday morning,Benzinga reports. They currently have an equal weight rating on the biopharmaceutical company’s stock. Several other analysts also recently commented on BMY. Daiwa Capital Markets raised Bristol-Myers Squibb from […]
